These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30148132)

  • 1. Hemodiafiltration Treatment for Severe Valproic Acid Intoxication: Case Report and Updated Systematic Literature Review.
    Tichelbäcker T; Herath J; Tampe B; Korsten P
    Front Med (Lausanne); 2018; 5():224. PubMed ID: 30148132
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup.
    Ghannoum M; Laliberté M; Nolin TD; MacTier R; Lavergne V; Hoffman RS; Gosselin S;
    Clin Toxicol (Phila); 2015 Jun; 53(5):454-65. PubMed ID: 25950372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal elimination in acute valproic acid poisoning.
    Thanacoody RH
    Clin Toxicol (Phila); 2009 Aug; 47(7):609-16. PubMed ID: 19656009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.
    Comstock G; Kilgallon K; Wang GS; Bourne D; Blanchette E; Stenson E
    J Med Toxicol; 2022 Jul; 18(3):239-242. PubMed ID: 35235162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe valproic acid intoxication: case study on the unbound fraction and the applicability of extracorporeal elimination.
    van den Broek MP; Sikma MA; Ververs TF; Meulenbelt J
    Eur J Emerg Med; 2009 Dec; 16(6):330-2. PubMed ID: 19424075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal management of valproic acid toxicity: a case report and review of the literature.
    Al Aly Z; Yalamanchili P; Gonzalez E
    Semin Dial; 2005; 18(1):62-6. PubMed ID: 15663767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-flux hemodialysis and levocarnitine in the treatment of severe valproic Acid intoxication.
    Temel V; Arikan M; Temel G
    Case Rep Emerg Med; 2013; 2013():526469. PubMed ID: 23762657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hemoperfusion and L-carnitine management in valproic acid overdose.
    Jung J; Eo E; Ahn KO
    Am J Emerg Med; 2008 Mar; 26(3):388.e3-4. PubMed ID: 18358983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Valproic Acid Intoxication Successfully Treated with Liver Support Therapy.
    Ge Y; Xu B; Zhu S; Li C; He Q; Zhu T; Fan R; Gong D
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):368-370. PubMed ID: 28481454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
    Lheureux PE; Penaloza A; Zahir S; Gris M
    Crit Care; 2005 Oct; 9(5):431-40. PubMed ID: 16277730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overdose with antiepileptic drugs: the efficacy of extracorporeal removal techniques.
    Moinho R; Dias A; Estanqueiro P; Farela Neves J
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal management of valproic acid overdose: a large regional experience.
    Singh SM; McCormick BB; Mustata S; Thompson M; Prasad GV
    J Nephrol; 2004; 17(1):43-9. PubMed ID: 15151258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid intoxication: sense and non-sense of haemodialysis.
    Meek MF; Broekroelofs J; Yska JP; Egbers PH; Boerma EC; van der Voort PH
    Neth J Med; 2004 Oct; 62(9):333-6. PubMed ID: 15635819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrecognized valproic acid intoxication.
    Hurdle AC; Moss RD
    Am J Emerg Med; 2009 Feb; 27(2):250.e1-2. PubMed ID: 19371546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
    Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
    Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.
    Rabindranath KS; Strippoli GF; Roderick P; Wallace SA; MacLeod AM; Daly C
    Am J Kidney Dis; 2005 Mar; 45(3):437-47. PubMed ID: 15754266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodiafiltration history, technology, and clinical results.
    Ronco C; Cruz D
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):231-43. PubMed ID: 17603976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal removal of toxic valproic acid levels in children.
    Dharnidharka VR; Fennell RS; Richard GA
    Pediatr Nephrol; 2002 May; 17(5):312-5. PubMed ID: 12042885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover Trial.
    Mineshima M; Takahashi S; Tomo T; Kawanishi H; Kawaguchi H; Minakuchi J; Nakanishi T; Sato T; Nitta K; Tsuchiya K; Masakane I; Itami N
    Blood Purif; 2019; 48(4):368-381. PubMed ID: 31311018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.